phorbolol myristate acetate has been researched along with dactinomycin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belizario, JE; Dinarello, CA | 1 |
| Chang, KC; Kang, YJ; Kim, HJ; Ko, YS; Lee, YS; Park, MK; Pyo, HS; Seo, HG; Yun-Choi, HS | 1 |
| Baert, JL; Brenner, C; de Launoit, Y; Mauen, S; Monté, D; Moser, M; Putmans, P; T'sas, F; Van Lint, C | 1 |
| Bober, A; Korzekwa, A; Okuda, K; Skarzynski, DJ; Woclawek-Potocka, I | 1 |
| Andriopoulos, N; Geiger, KK; Hoetzel, A; Humar, M; Loop, T; Pahl, HL; Pannen, BH; Roesslein, M; Schmidt, R | 1 |
5 other study(ies) available for phorbolol myristate acetate and dactinomycin
| Article | Year |
|---|---|
Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Topics: Animals; Cell Cycle; Cholera Toxin; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Fibrosarcoma; G1 Phase; Humans; Indomethacin; Interleukin-1; Interleukin-6; Mice; Premedication; Tetradecanoylphorbol Acetate; Time Factors; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
Induction of manganese-superoxide dismutase by YS 51, a synthetic 1-(beta-naphtylmethyl)6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline alkaloid: implication for anti-inflammatory actions.
Topics: Animals; Blotting, Northern; Curcumin; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Flavonoids; Gene Expression Regulation, Enzymologic; HeLa Cells; Humans; Imidazoles; Indoles; JNK Mitogen-Activated Protein Kinases; Maleimides; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phorbol Esters; Phosphorylation; Pulmonary Artery; Pyridines; RNA, Messenger; Sheep; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Tetrahydroisoquinolines; Tumor Necrosis Factor-alpha | 2004 |
Expression of the Ets transcription factor Erm is regulated through a conventional PKC signaling pathway in the Molt4 lymphoblastic cell line.
Topics: Cell Line, Tumor; Dactinomycin; DNA-Binding Proteins; Gene Expression Regulation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Protein Kinase C; RNA, Messenger; Sequence Deletion; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription Factors; Transcription, Genetic; Up-Regulation | 2005 |
Equol and para-ethyl-phenol stimulate prostaglandin F(2alpha) secretion in bovine corpus luteum: intracellular mechanisms of action.
Topics: Animals; Calcium; Cattle; Cells, Cultured; Corpus Luteum; Dactinomycin; Diet; Dinoprost; Equol; Estrenes; Female; Glycine max; Isoflavones; Luteinizing Hormone; Phenols; Phytoestrogens; Pyrrolidinones; Staurosporine; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2006 |
The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun.
Topics: Animals; Antibodies; CD28 Antigens; CD3 Complex; Cell Line; Cell Line, Tumor; Dactinomycin; DNA; Enzyme Inhibitors; Humans; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Mice; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Binding; Protein Kinase C; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Serine; T-Lymphocyte Subsets; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2007 |